Clinical Trials Browser

Phase 2 × Muscle Invasive Bladder Urothelial Carcinoma × Gemcitabine × Clear all

NCT06257017 2025-04-04

Surveillance of the Genetic Signature in Circulating Tumor DNA for Guiding Adjuvant Chemotherapy in Urothelial Carcinoma

Phase 2 Recruiting

Muscle Invasive Bladder Urothelial Carcinoma